Literature DB >> 20872260

Microwave-assisted solid-phase peptide synthesis of the 60-110 domain of human pleiotrophin on 2-chlorotrityl resin.

Irene Friligou1, Evangelia Papadimitriou, Dimitrios Gatos, John Matsoukas, Theodore Tselios.   

Abstract

A fast and efficient microwave-assisted solid phase peptide synthesis (MW-SPPS) of a 51mer peptide, the main heparin-binding site (60-110) of human pleiotrophin (hPTN), using 2-chlorotrityl chloride resin (CLTR-Cl) following the 9-fluorenylmethyloxycarbonyl/tert-butyl (Fmoc/tBu) methodology and with the standard N,N'-diisopropylcarbodiimide/1-hydroxybenzotriazole (DIC/HOBt) coupling reagents, is described. An MW-SPPS protocol was for the first time successfully applied to the acid labile CLTR-Cl for the faster synthesis of long peptides (51mer peptide) and with an enhanced purity in comparison to conventional SPPS protocols. The synthesis of such long peptides is not trivial and it is generally achieved by recombinant techniques. The desired linear peptide was obtained in only 30 h of total processing time and in 51% crude yield, in which 60% was the purified product obtained with 99.4% purity. The synthesized peptide was purified by reversed phase high performance liquid chromatography (RP-HPLC) and identified by electrospray ionization mass spectrometry (ESI-MS). Then, the regioselective formation of the two disulfide bridges of hPTN 60-110 was successfully achieved by a two-step procedure, involving an oxidative folding step in dimethylsulfoxide (DMSO) to form the Cys(77)-Cys(109) bond, followed by iodine oxidation to form the Cys(67)-Cys(99) bond.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20872260     DOI: 10.1007/s00726-010-0753-6

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  7 in total

1.  A Macrocyclic Agouti-Related Protein/[Nle4,DPhe7]α-Melanocyte Stimulating Hormone Chimeric Scaffold Produces Subnanomolar Melanocortin Receptor Ligands.

Authors:  Mark D Ericson; Katie T Freeman; Sathya M Schnell; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2017-01-17       Impact factor: 7.446

2.  Discovery of a stable tripeptide targeting the N-domain of CRF1 receptor.

Authors:  George Liapakis; Vlasios Karageorgos; Ioannis Andreadelis; George G Holz; Eirini Dermitzaki; Golfo G Kordopati; Evgenios Κ Stylos; Katerina Spyridaki; Smaragda Poulaki; Dimitris Ntountaniotis; Stelios Sakellaris; Marianna Vanioti; Androniki Kostagianni; Konstantinos D Marousis; Georgios Leonis; George Kokotos; Maria Venihaki; Georgios A Spyroulias; Theodoros Tselios; Andrew Margioris; Andreas G Tzakos; Thomas Mavromoustakos
Journal:  Amino Acids       Date:  2020-09-29       Impact factor: 3.520

3.  Mannosylated Linear and Cyclic Single Amino Acid Mutant Peptides Using a Small 10 Amino Acid Linker Constitute Promising Candidates Against Multiple Sclerosis.

Authors:  Stephanie Day; Theodore Tselios; Maria-Eleni Androutsou; Anthi Tapeinou; Irene Frilligou; Lily Stojanovska; John Matsoukas; Vasso Apostolopoulos
Journal:  Front Immunol       Date:  2015-04-07       Impact factor: 7.561

4.  Efficient Method for the Concentration Determination of Fmoc Groups Incorporated in the Core-Shell Materials by Fmoc-Glycine.

Authors:  Elżbieta Szczepańska; Beata Grobelna; Jacek Ryl; Amanda Kulpa; Tadeusz Ossowski; Paweł Niedziałkowski
Journal:  Molecules       Date:  2020-09-01       Impact factor: 4.411

5.  The Human Myelin Proteome and Sub-Metalloproteome Interaction Map: Relevance to Myelin-Related Neurological Diseases.

Authors:  Christos T Chasapis; Konstantinos Kelaidonis; Harry Ridgway; Vasso Apostolopoulos; John M Matsoukas
Journal:  Brain Sci       Date:  2022-03-24

6.  Chemical synthesis of membrane proteins: a model study on the influenza virus B proton channel.

Authors:  A C Baumruck; D Tietze; L K Steinacker; A A Tietze
Journal:  Chem Sci       Date:  2018-01-22       Impact factor: 9.825

7.  A Cyclic Altered Peptide Analogue Based on Myelin Basic Protein 87-99 Provides Lasting Prophylactic and Therapeutic Protection Against Acute Experimental Autoimmune Encephalomyelitis.

Authors:  Mary Emmanouil; Vivian Tseveleki; Iro Triantafyllakou; Agathi Nteli; Theodore Tselios; Lesley Probert
Journal:  Molecules       Date:  2018-01-31       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.